Home
Hidradenitis Suppurativa
The most recent advances in understanding and managing hidradenitis suppurativa
Inflammatory Skin Diseases and the Risk of Chronic Kidney Disease – Population-Based Case-control and Cohort analyses
Impact of the COVID-19 pandemic on the course and management of chronic inflammatory immune-mediated skin diseases: What’s the evidence?
Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine during Ixekizumab treatment for hidradenitis suppurativa
Association of hidradenitis suppurativa with Crohn’s disease
It’s a Numbers Thing
Gut Reaction
Hidradenitis suppurativa in East and Southeast Asian populations: a systematic review and meta-analysis
Nothing to Kid About
Guidelines Issued for Managing Hidradenitis Suppurativa
1
2
3
4
5
×